2026 Santa Barbara Dermatology Meeting

About this event

Each year, nationally recognized leaders in medical, procedural, and aesthetic medicine convene in Santa Barbara to discuss and review the current state of knowledge in their respective dermatologic specialties. This program in medical dermatology features key clinical topics, including atopic dermatitis, acne vulgaris, cutaneous cancers, rosacea, psoriasis, and other important issues. Aesthetic medicine continues to be a growing specialty in the milieu of the aging American population and medical consumers’ ever-increasing desire to achieve the best possible quality of life at any age.

• Agenda

• Brochure

• CE Credit

• Course Directors & Faculty

• Registration

Target Audience

Dermatologists, Nurse Practitioners, Physician Assistants, and Registered Nurses.

Agenda

THURSDAY December 3, 2026

2:00 p.m. -5:00 p.m.

Registration and Check-In

FRIDAY December 4, 2026

7:00-4:00 p.m.

Registration Open

7:00-8:30 a.m.

Breakfast

8:30-9:00 a.m.

Lecture: Update on Alopecia & the New Treatments

Neal Bhatia, MD

9:00-9:30 a.m.

Lecture: Lessons Learned From Audits

Brent Moody, MD

9:30-10:00 a.m.

Lecture: Exciting Updates and Challenges in Psoriasis Care

April Armstrong, MD

10:00-10:20 a.m.

Break

10:20-10:50 a.m.

Lecture: Therapeutic Advances in Pediatric Dermatology

Anthony Mancini, MD

10:50-11:20 a.m.

Panel Q&A

Morning Panel: Neal Bhatia, MD; Brent Moody, MD; April Armstrong, MD; Anthony Mancini, MD

11:20-11:50 a.m.

Lecture: Double Duty: Selecting or Avoiding Psoriasis Therapy by Dual Indication

Kristina Callas Duffin, MD

11:50-1:30 p.m.

Lunch/Break/Exhibits

1:30-2:00 p.m.

Lecture: Update on Chronic Urticaria

Ted Lain, MD

2:00-2:30 p.m.

Lecture: TBD

TBD

2:30-3:00 p.m.

Lecture: Navigating Cosmeceuticals

Kavita Mariwalla, MD

3:00-4:00 p.m.

Lecture: Great Cases in Dermatopathology

Bruce Ragsdale, MD

SATURDAY December 5, 2026

7:00-4:00 p.m.

Registration Open

7:00-8:30 a.m.

Breakfast

8:30-9:00 a.m.

Lecture: Billing & Coding

Brent Moody, MD

9:00-9:30 a.m.

Lecture: The Child with a Red Rash

Anthony Mancini, MD

9:30-10:00 a.m.

Lecture: Atopic Dermatology: Systemics Update

Eric Simpson, MD

10:00 10:20 a.m.

Break

10:20-10:50 a.m.

Keynote Lecture: Stopping the Spiral in Hidradenitis

April Armstrong, MD

10:50-11:10 a.m.

Panel Q&A

Morning Panel: Brent Moody, MD; Anthony Mancini, MD; Eric Simpson, MD; April Armstrong, MD

11:10-12:00 p.m.

Lecture: Surgical Dermatology Pearls

Roberta Sengelmann, MD: Kavita Mariwalla, MD; Brent Moody, MD

12:00-1:30 p.m.

Lunch/Break/Exhibits

1:30-2:30 p.m.

Therapeutics Master Panel

April Armstrong, MD; Ted Lain, MD; Anthony Mancini, MD; Michael Heffernan, MD

2:30-4:30 p.m.

LIVE Patient Demonstration

Roberta Sengelmann, MD; Kavita Mariwalla, MD

SUNDAY December 6, 2026

7:00-12:00 p.m.

Reception Desk Open

7:00-8:30 a.m.

Breakfast

8:30-9:00 a.m.

Lecture: Controversies in Surgical Dermatology

Roberta Sengelmann, MD

9:00-9:30 a.m.

Lecture: Skin: The Frontline Longevity Organ

Ted Lain, MD

9:30-10:00 a.m.

Lecture: When Bad Things Happen to Good Dermatologists: Learning From Complications Conference

Eric Simpson, MD

10:00-10:30 a.m.

Lecture: Dermatology Therapeutic Pipeline

Neal Bhatia, MD

10:30-11:00 a.m.

Morning Q&A

Morning Panel: Ted Lain, MD; Eric Simpson, MD; Neal Bhatia, MD

11:00-12:00 p.m.

Lecture: Grand Rounds

Neal Bhatia, MD; Eric Simpson, MD; Michael Heffernan, MD

12:00 p.m.

Adjourn/Box Lunch

Course Directors

April Armstrong, MD FAAD

Dr. April Armstrong is Professor and Chief of Dermatology at University of California Los Angeles (UCLA). She is an internationally renowned dermatologist and clinical researcher in inflammatory skin diseases including psoriasis, atopic dermatitis, and HS.

Dr. Armstrong obtained her medical degree from Harvard Medical School and completed dermatology residency at Harvard. She also obtained a Master of Public Health degree from Harvard School of Public Health. Prior to being the Chief of Dermatology at UCLA, Dr. Armstrong served as Associate Dean for Clinical Research at the University of Southern California (USC), where she led initiatives to improve research infrastructure and streamline processes to provide an efficient environment for research. She also served as Vice Chair in the Department of Dermatology at USC, as well as at the University of California Davis and University of Colorado previously.

Dr. Armstrong is a federally funded investigator whose research focuses on (1) evaluating novel systemic and topical therapies for inflammatory skin diseases, (2) identifying treatment goals and comorbidities associated with skin diseases, and (3) increasing patient access using innovative, technology-enabled healthcare delivery methods. Dr. Armstrong has conducted over 150 clinical trials and published over 500 articles in scientific journals.

Dr. Armstrong has a long history of service to the medical profession on a national and international level. She serves as a board member of the American Academy of Dermatology, immediate Past Chair of the Medical Board at the National Psoriasis Foundation, Co-President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), councilor for the International Eczema Council and International Psoriasis Council, and a board member for the International Dermatology Outcome Measures and the California Society of Dermatology and Dermatological Surgery (CalDerm). She is also an editorial board member of JAMA Dermatology and had also served on the editorial boards of JAAD and other journals. Dr. Armstrong is past President of the American DermatoEpidemiology Network and Sacramento Valley Dermatology Society.

Dr. Armstrong is also a passionate educator, having mentored numerous medical students, residents, and postdoctoral research fellows. She has received institutional and national teaching awards for her educational efforts.

Neal Bhatia, MD

Dr. Neal Bhatia is a board-certified dermatologist in San Diego, California. He serves as Director of Clinical Dermatology at Therapeutics Clinical Research and as chief medical editor for Practical Dermatology. He is widely published and has a background in immunology as well as interests in mechanisms of therapy, skin cancer, and medical dermatology

Michael Heffernan, MD

Dr. Heffernan is an internationally recognized complex medical dermatologist and clinical trialist. After serving as the founding chair of Dermatology at the Wright State University Boonshoft School of Medicine he served as a Distinguished Medical Fellow for Eli Lilly & Co. He is now the co-owner of San Luis Dermatology & Laser Clinic and he is the US Dermatology Lead for Probity Medical Research. Dr. Heffernan has published over 80 peer reviewed articles and textbook chapters. He has been the principle investigator for nearly 150 research studies and he has provided over 500 invited lectures around the globe

Learning Objectives

As a result of participating in this activity, the participants will be able to:

1. Discuss new approaches to therapy including pathway targeted therapy in the treatment of melanoma.

2. Assess the role of diagnostic tools and technology in diagnosis and detection of skin cancers.

3. Compare and contrast the efficacy and safety of agents, devices, and techniques currently available in aesthetic and procedural dermatology.

4. Integrate into daily practice evidence-based recommendations on new and emerging therapies for common dermatologic diseases.

5. Analyze treatment approaches for the pediatric patient with common as well as complex skin diseases.

6. Implement updated strategies for managing acne, rosacea, atopic dermatitis, contact dermatitis and psoriasis.

7. Recognize the factors that are important in selecting appropriate filler agents for treating different areas of the face and targeted planar depths.

8. Determine the appropriate nonsurgical techniques for facial rejuvenation based on an enhanced understanding of facial anatomy.

9. Explain the roles of currently available biologic agents in the treatment of psoriasis and psoriatic arthritis, and appropriately incorporate newer biologics into therapeutic practice as these become available.

10. Incorporate the recent research advances in understanding and treating pediatric dermatology issues such as atopic dermatitis and pediatric acne.

Continuing Education Credit

Joint Provider Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville School of Medicine and the Foundation for Dermatology Education. The University of Louisville is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit

The University of Louisville Continuing Medical Education office designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please note: California PAs, California RNs and California NPs can all earn AMA PRA Category 1 Credit(s)™ .

Nursing Credit

This program has been approved by the Kentucky Board of Nursing for 18.3 continuing education credits through University of Louisville Hospital, provider number 4-0068-12-26-1483. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Completion criteria to obtain CE's: Attend entire session and complete the evaluation.

Special Services

All individuals are encouraged to participate. To request disability arrangements, please contact Gregory Cameron at least 14 days prior to the date of this program. Continuing Medical Education and Professional Development fully complies with the legal requirements of the ADA and the rules and regulations thereof.

Registration

Registration Options and Fees:

1. Residents/Fellows $150

2. All Others - $750

3. Industry Representative $2,000

Register Here

Refund Policy

Requests for cancellation must be submitted to c hse@louisville.edu on or before Friday, November 20, 2026. Requests received on or before Friday, November 21, 2025 will receive a full refund less a $50 processing fee. No refund will be given for requests received after Friday, November 20, 2026.

Lodging/Reservations

Details for Lodging/Reservations will be forwarded upon completion of registration.

General Venue Information (Not For Reservations)

CLICK HERE to go to the Ojai Valley Inn Website

Accreditation Disclosure

As a provider accredited by the ACCME, the Office of CME&PD, School of Medicine, University of Louisville, must ensure balance, independence, objectivity, and scientific rigor in all its accredited educational activities. All Planners, faculty, reviewers, and other persons that affected the content of this CME activity were required to submit a financial disclosure form from which relevant conflicts of interest were determined. If any relevant financial relationship(s) with ineligible companies were disclosed, the materials each of them prepared for this program (or influenced) were peer-reviewed and determined to be without ineligible company bias, were considered fair and balanced in terms of therapeutic options, and presented evidence-based content. All relevant financial relationships with ineligible organizations have been mitigated prior to this activity.

Learner Consent Statement

Names or contact information of learners will not be shared with any ineligible company or its agents without the explicit consent of the individual learner.

Acknowledgments

We thank our supporting and exhibiting companies for their participation in the conference! A final listing of supporters and exhibitors will be available at the meeting.